Ginkgolide B
in Ginkgo biloba
What it isGinkgo constituent and a platelet-activating factor antagonist.
Why this onePAF antagonism is the mechanistic basis for ginkgo’s reported bleeding risk.
What limits itIt matters most alongside anticoagulants and antiplatelets, where patients rarely mention taking it.
FDA-approved for
- Ginkgo biloba constituent (supplement)
NO BOXED WARNINGS
Principal riskBleeding risk with anticoagulants